EAACI Congress 2024

Back
31 May - 03 June 2024 Valencia, Spain

Efficacy and Safety of Oral Deucrictibant, a Potent Bradykinin B2 Receptor Antagonist, in Prophylaxis of Hereditary Angioedema Attacks: Results of CHAPTER-1 Phase 2 Trial

Saturday 01 Jun, 17:21 PM - 17:33 PM Valencia, Spain